Swedish clinical guidelines--prevention and management of metabolic risk in patients with severe psychiatric disorders

Nord J Psychiatry. 2010 Oct;64(5):294-302. doi: 10.3109/08039488.2010.500397.

Abstract

Individuals with severe psychiatric disorders are more likely than the population at large to develop metabolic derangements such as overweight and diabetes. Cardiovascular disease is also more frequently seen in this group. Contributing factors may include inappropriate diet or lack of physical activity, but antipsychotic medication may also play a role. Seven Swedish specialist medical societies have collaborated in formulating a set of concise clinically applicable guidelines-reproduced here in modified form-for the prevention and management of metabolic risk in this patient group. The importance of implementation is emphasized.

Publication types

  • Practice Guideline

MeSH terms

  • Adolescent
  • Adult
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Child
  • Humans
  • Hyperglycemia / therapy
  • Hyperlipidemias / therapy
  • Mental Disorders / complications*
  • Mental Disorders / metabolism
  • Mental Disorders / therapy
  • Metabolic Syndrome / prevention & control*
  • Metabolic Syndrome / psychology
  • Metabolic Syndrome / therapy
  • Obesity / prevention & control
  • Obesity / therapy

Substances

  • Antipsychotic Agents